Statins and risk of breast cancer recurrence

References

• LakhaFTheodoratouEFarringtonSMStatin use and association with colorectal cancer survival and risk: case control study with prescription data linkageBMC Cancer20121248723088590
   PubMed Web of Science ®Google Scholar
• Garcia-RuizCMoralesAFernandez-ChecaJCStatins and protein prenylation in cancer cell biology and therapyAnticancer Agents Med Chem20121230331522413970
   PubMed Web of Science ®Google Scholar
• Freed-PastorWAMizunoHZhaoXMutant p53 disrupts mammary tissue architecture via the mevalonate pathwayCell201214824425822265415
   PubMed Web of Science ®Google Scholar
• SomaMRCorsiniAPaolettiRCholesterol and mevalonic acid modulation in cell metabolism and multiplicationToxicol Lett199264–65115
   Web of Science ®Google Scholar
• ThurnherMGruenbacherGNussbaumerORegulation of mevalonate metabolism in cancer and immune cellsBiochim Biophys Acta201318311009101523524243
   PubMed Web of Science ®Google Scholar
• ClendeningJWPandyraABoutrosPCDysregulation of the mevalonate pathway promotes transformationProc Natl Acad Sci U S A2010107150511505620696928
   PubMed Web of Science ®Google Scholar
• BorgquistSJögiAPonténFRydénLBrennanDJJirströmKPrognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancerBreast Cancer Res200810R7918808688
   PubMed Web of Science ®Google Scholar
• LarssonOCarlbergMRequirement for isoprenoid-dependent post-translational modifications in the cell-cycle progression of human breast-cancer cellsInt J Oncol1992148949321584571
   PubMed Web of Science ®Google Scholar
• HilvoMDenkertCLehtinenLNovel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progressionCancer Res2011713236324521415164
   PubMed Web of Science ®Google Scholar
• CuelloFMKatoCSDíazSDOwenGEfectos de las estatinas en cáncer: ¿potencial rol en terapéutica y prevención? [Effects of statins in cancer]Rev Med Chil2013141227236 Spanish23732497
   PubMed Web of Science ®Google Scholar
• SinghSSinghPPStatin a day keeps cancer at bayWorld J Clin Oncol20134434623696961
   PubMedGoogle Scholar
• ZanfardinoMSpampanatoCDe CiccoRSimvastatin reduces melanoma progression in a murine modelInt J Oncol2013431763177024101161
   PubMed Web of Science ®Google Scholar
• WachtershauserAAkogluBSteinJHMG-CoA reductase inhibitor mevastatin enhances the growth inhibitory effect of butyrate in the colorectal carcinoma cell line Caco-2Carcinogenesis2001221061106711408350
   PubMed Web of Science ®Google Scholar
• SpampanatoCDe MariaSSarnataroMSimvastatin inhibits cancer cell growth by inducing apoptosis correlated to activation of Bax and down-regulation of BCL-2 gene expressionInt J Oncol20124093594122134829
   PubMed Web of Science ®Google Scholar
• DenoyelleCVasseMKörnerMCerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: an in vitro studyCarcinogenesis2001221139114811470741
   PubMed Web of Science ®Google Scholar
• MandalCCGhosh-ChoudhuryNYonedaTChoudhuryGGSimvastatin prevents skeletal metastasis of breast cancer by an antagonistic interplay between p53 and CD44J Biol Chem2011286113141132721199873
   PubMed Web of Science ®Google Scholar
• BonovasSStatins: do they have a potential role in cancer prevention and modifying cancer-related outcomes?Drugs2014741841184825288321
   PubMed Web of Science ®Google Scholar
• BonovasSLytrasTSitarasNMStatin use and breast cancer: do we need more evidence and what should this be?Expert Opin Drug Saf20141327127524517162
   PubMed Web of Science ®Google Scholar
• PisantiSPicardiPCiagliaED’AlessandroABifulcoMNovel prospects of statins as therapeutic agents in cancerPharmacol Res201488849825009097
   PubMed Web of Science ®Google Scholar
• DesaiPChlebowskiRCauleyJAProspective analysis of association between statin use and breast cancer risk in the Women’s Health InitiativeCancer Epidemiol Biomarkers Prev2013221868187623975947
   PubMed Web of Science ®Google Scholar
• CauleyJAZmudaJMLuiLYLipid-lowering drug use and breast cancer in older women: a prospective studyJ Womens Health (Larchmt)20031274975614588125
   PubMed Web of Science ®Google Scholar
• KumarASEssermanLJStatins: health-promoting agents show promise for breast cancer preventionClin Breast Cancer2005645545916381630
   PubMedGoogle Scholar
• DemierreMFHigginsPDGruberSBHawkELippmanSMStatins and cancer preventionNat Rev Cancer2005593094216341084
   PubMed Web of Science ®Google Scholar
• ZhongSZhangXChenLMaTTangJZhaoJStatin use and mortality in cancer patients: systematic review and meta-analysis of observational studiesCancer Treat Rev20154155456725890842
   PubMed Web of Science ®Google Scholar
• NielsenSFNordestgaardBGBojesenSEStatin use and reduced cancer-related mortalityN Engl J Med20123671792180223134381
   PubMed Web of Science ®Google Scholar
• AhernTPPedersenLTarpMStatin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort studyJ Natl Cancer Inst20111031461146821813413
   PubMed Web of Science ®Google Scholar
• BoudreauDMYuOChubakJComparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancerBreast Cancer Res Treat201414440541624557337
   PubMed Web of Science ®Google Scholar
• ChaeYKValsecchiMEKimJReduced risk of breast cancer recurrence in patients using ACE inhibitors, ARBs, and/or statinsCancer Invest20112958559321936625
   PubMed Web of Science ®Google Scholar
• KwanMLHabelLAFlickEDQuesenberryCPCaanBPost-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivorsBreast Cancer Res Treat200810957357917674197
   PubMed Web of Science ®Google Scholar
• NickelsSVrielingASeiboldPMortality and recurrence risk in relation to the use of lipid-lowering drugs in a prospective breast cancer patient cohortPLoS One20138e7508824086446
   PubMed Web of Science ®Google Scholar
• ParkJHMcMillanDCHorganPGRoxburghCSThe impact of anti-inflammatory agents on the outcome of patients with colorectal cancerCancer Treat Rev201440687723773805
   PubMed Web of Science ®Google Scholar
• BonovasSFilioussiKTsavarisNSitarasNMUse of statins and breast cancer: a meta-analysis of seven randomized clinical trials and nine observational studiesJ Clin Oncol2005238606861216260694
   PubMed Web of Science ®Google Scholar
• BrewerTMMasudaHLiuDDStatin use in primary inflammatory breast cancer: a cohort studyBr J Cancer201310931832423820253
   PubMed Web of Science ®Google Scholar
• CardwellCRHicksBMHughesCMurrayLJStatin use after diagnosis of breast cancer and survival: a population-based cohort studyEpidemiology201526687825304447
   PubMed Web of Science ®Google Scholar
• DesaiPLehmanAChlebowskiRTStatins and breast cancer stage and mortality in the Women’s Health InitiativeCancer Causes Control20152652953925736184
   PubMed Web of Science ®Google Scholar
• MurtolaTJVisvanathanKArtamaMVainioHPukkalaEStatin use and breast cancer survival: a nationwide cohort study from FinlandPLoS One20149e11023125329299
   PubMed Web of Science ®Google Scholar
• GraafMRRichelDJvan NoordenCJGuchelaarHJEffects of statins and farnesyltransferase inhibitors on the development and progression of cancerCancer Treat Rev20043060964115531395
   PubMed Web of Science ®Google Scholar
• BlackwellKLHaroonZAShanSTamoxifen inhibits angiogenesis in estrogen receptor-negative animal modelsClin Cancer Res200064359436411106254
   PubMed Web of Science ®Google Scholar
• DulakJJozkowiczAAnti-angiogenic and anti-inflammatory effects of statins: relevance to anti-cancer therapyCurr Cancer Drug Targets2005557959416375664
   PubMed Web of Science ®Google Scholar
• MorGSapiEAbrahamsVMInteraction of the estrogen receptors with the Fas ligand promoter in human monocytesJ Immunol200317011412212496390
   PubMed Web of Science ®Google Scholar
• SleijferSvan der GaastAPlantingASStoterGVerweijJThe potential of statins as part of anti-cancer treatmentEur J Cancer20054151652215737555
   PubMed Web of Science ®Google Scholar
• NelsonERWardellSEJasperJS27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiologyScience20133421094109824288332
   PubMed Web of Science ®Google Scholar
• ZhouQAtadjaPDavidsonNEHistone deacetylase inhibitor LBH589 reactivates silenced estrogen receptor alpha (ER) gene expression without loss of DNA hypermethylationCancer Biol Ther20076646917172825
   PubMed Web of Science ®Google Scholar
• KumarASBenzCCShimVMinamiCAMooreDHEssermanLJEstrogen receptor-negative breast cancer is less likely to arise among lipophilic statin usersCancer Epidemiol Biomarkers Prev2008171028103318463402
   PubMed Web of Science ®Google Scholar
• ByersTStatins, breast cancer, and an invisible switch?Cancer Epidemiol Biomarkers Prev2008171026102718463398
   PubMed Web of Science ®Google Scholar
• BrennanDJLaursenHO’ConnorDPTumor-specific HMG-CoA reductase expression in primary premenopausal breast cancer predicts response to tamoxifenBreast Cancer Res201113R1221281480
   PubMed Web of Science ®Google Scholar
• AndersCKHsuDSBroadwaterGYoung age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expressionJ Clin Oncol2008263324333018612148
   PubMed Web of Science ®Google Scholar
• LundMJTriversKFPorterPLRace and triple negative threats to breast cancer survival: a population-based study in Atlanta, GABreast Cancer Res Treat200911335737018324472
   PubMed Web of Science ®Google Scholar
• ShannonCSmithIEBreast cancer in adolescents and young womenEur J Cancer2003392632264214642925
   PubMed Web of Science ®Google Scholar
• GarwoodERKumarASBaehnerFLFluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancerBreast Cancer Res Treat201011913714419728082
   PubMed Web of Science ®Google Scholar
• BjarnadottirORomeroQBendahlPOTargeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trialBreast Cancer Res Treat201313849950823471651
   PubMed Web of Science ®Google Scholar